Malignant gliomas often exhibit p53 mutation and/or EGFR amplification, and the tumor suppressor PTEN (phosphatase and tensin homolog) is frequently deleted in GBM, leading to downstream activation of the Akt pathway17, 19. The gene discussed is PTEN; the disease is glioblastoma.